Duneesha De Alwis1, Michael T Lynskey2, Angela M Reiersen1, Arpana Agrawal3. 1. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO USA. 2. Kings College, Addictions Department, London, UK. 3. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO USA. Electronic address: agrawala@psychiatry.wustl.edu.
Abstract
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is associated with substance use and substance use disorders (SUD). However, relatively little is known about the relationship between DSM-IV ADHD subtypes and substance use or DSM-IV abuse/dependence in epidemiological samples. METHODS: Data were obtained from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC, N = 33,588). Respondents reported on ADHD symptoms (DSM-IV) for the period of time when they were 17 years or younger. Lifetime use and DSM-IV abuse/dependence of alcohol, nicotine, cannabis, cocaine, sedatives, stimulants and heroin/opiates were compared across those with ADHD symptoms but no diagnosis (ADHDsx; N = 17,009), the Combined (ADHD-C; N = 361), Predominantly Inattentive (ADHD-I; N = 325), and the Predominantly Hyperactive-Impulsive (ADHD-HI; N = 279) ADHD subtypes. Taking a more dimensional approach, inattentive and hyperactive-impulsive symptom counts and their associations with substance use and misuse were also examined. RESULTS: After adjustments for conduct disorder, major depressive disorder, any anxiety disorder and other socio-demographic covariates, substance use and SUD were associated with ADHDsx, ADHD-C, ADHD-I and ADHD-HI. Overall, substance use and SUD were more weakly associated with the ADHDsx group compared to the three ADHD diagnostic groups. Statistically significant differences were not evident across the three diagnostic groups. Hyperactive-impulsive symptoms were more consistently associated with substance use and SUD compared to inattentive symptoms. CONCLUSIONS: ADHD subtypes are consistently associated with substance use and SUD. The relatively stronger association of hyperactive/impulsive symptoms with substance use and abuse/dependence is consistent with the extant literature noting impulsivity as a precursor of substance use and SUD.
BACKGROUND:Attention-deficit/hyperactivity disorder (ADHD) is associated with substance use and substance use disorders (SUD). However, relatively little is known about the relationship between DSM-IV ADHD subtypes and substance use or DSM-IV abuse/dependence in epidemiological samples. METHODS: Data were obtained from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC, N = 33,588). Respondents reported on ADHD symptoms (DSM-IV) for the period of time when they were 17 years or younger. Lifetime use and DSM-IV abuse/dependence of alcohol, nicotine, cannabis, cocaine, sedatives, stimulants and heroin/opiates were compared across those with ADHD symptoms but no diagnosis (ADHDsx; N = 17,009), the Combined (ADHD-C; N = 361), Predominantly Inattentive (ADHD-I; N = 325), and the Predominantly Hyperactive-Impulsive (ADHD-HI; N = 279) ADHD subtypes. Taking a more dimensional approach, inattentive and hyperactive-impulsive symptom counts and their associations with substance use and misuse were also examined. RESULTS: After adjustments for conduct disorder, major depressive disorder, any anxiety disorder and other socio-demographic covariates, substance use and SUD were associated with ADHDsx, ADHD-C, ADHD-I and ADHD-HI. Overall, substance use and SUD were more weakly associated with the ADHDsx group compared to the three ADHD diagnostic groups. Statistically significant differences were not evident across the three diagnostic groups. Hyperactive-impulsive symptoms were more consistently associated with substance use and SUD compared to inattentive symptoms. CONCLUSIONS:ADHD subtypes are consistently associated with substance use and SUD. The relatively stronger association of hyperactive/impulsive symptoms with substance use and abuse/dependence is consistent with the extant literature noting impulsivity as a precursor of substance use and SUD.
Authors: R C Kessler; S Avenevoli; K A McLaughlin; J Greif Green; M D Lakoma; M Petukhova; D S Pine; N A Sampson; A M Zaslavsky; K Ries Merikangas Journal: Psychol Med Date: 2012-01-25 Impact factor: 7.723
Authors: Erik G Willcutt; Joel T Nigg; Bruce F Pennington; Mary V Solanto; Luis A Rohde; Rosemary Tannock; Sandra K Loo; Caryn L Carlson; Keith McBurnett; Benjamin B Lahey Journal: J Abnorm Psychol Date: 2012-05-21
Authors: M D Glantz; J C Anthony; P A Berglund; L Degenhardt; L Dierker; A Kalaydjian; K R Merikangas; A M Ruscio; J Swendsen; R C Kessler Journal: Psychol Med Date: 2008-12-02 Impact factor: 7.723
Authors: Ujjwal P Ramtekkar; Angela M Reiersen; Alexandre A Todorov; Richard D Todd Journal: J Am Acad Child Adolesc Psychiatry Date: 2010-03 Impact factor: 8.829
Authors: Patrick D Quinn; Erik Pettersson; Sebastian Lundström; Henrik Anckarsäter; Niklas Långström; Clara Hellner Gumpert; Henrik Larsson; Paul Lichtenstein; Brian M D'Onofrio Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-12-30 Impact factor: 3.568
Authors: Stéphanie Baggio; Joseph Studer; Ana Fructuoso; Véronique S Grazioli; Patrick Heller; Hans Wolff; Gerhard Gmel; Nader Perroud Journal: Int J Public Health Date: 2018-07-25 Impact factor: 3.380
Authors: Alessandro Pallucchini; Marco Carli; Angelo G I Maremmani; Marco Scarselli; Giulio Perugi; Icro Maremmani Journal: J Clin Med Date: 2021-05-05 Impact factor: 4.241